The US Patent and Trademark Office published on Oct. 2 two patent applications related to RNA interference.
The first — No. 20030186909 — is entitled “Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors,” and lists Sirna Therapeutics researcher James McSwiggen as its inventor.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.